| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |